Description
An adenosine A3 receptor agonist (Ki = 430.5 nM for the human receptor expressed in CHO cells); inhibits LPS-induced TNF-α production in primary cultured human lung macrophages (pD2 = 6.9); increases contraction of isolated guinea pig trachea at 0.1 μM and increases bronchoconstriction in vivo at 3 μg/kg in a guinea pig model of ovalbumin-sensitized asthma; radiolabeled form binds to rat adenosine A1 and A3 receptors (Kds = 3.42 and 1.48 nM in COS-7 and CHO cells, respectively) and canine adenosine A2a receptors (Kd = 25.1 nM in COS-7)
Formal name: 1-[6-[[(4-aminophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-β-D-ribofuranuronamide
Synonyms:
Molecular weight: 399.4
CAS: 152918-26-8
Purity: ≥98%
Formulation: A crystalline solid